nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Ticagrelor—coronary artery disease	0.0442	0.0901	CbGbCtD
Darifenacin—CYP3A4—Fenofibrate—coronary artery disease	0.0394	0.0803	CbGbCtD
Darifenacin—CYP2D6—Niacin—coronary artery disease	0.0325	0.0664	CbGbCtD
Darifenacin—CYP3A4—Gemfibrozil—coronary artery disease	0.0315	0.0642	CbGbCtD
Darifenacin—CYP2D6—Timolol—coronary artery disease	0.0303	0.0617	CbGbCtD
Darifenacin—CYP3A4—Clopidogrel—coronary artery disease	0.0273	0.0557	CbGbCtD
Darifenacin—CYP2D6—Captopril—coronary artery disease	0.0266	0.0543	CbGbCtD
Darifenacin—CYP2D6—Simvastatin—coronary artery disease	0.0257	0.0525	CbGbCtD
Darifenacin—CYP3A4—Eplerenone—coronary artery disease	0.0254	0.0518	CbGbCtD
Darifenacin—CYP2D6—Pravastatin—coronary artery disease	0.0252	0.0513	CbGbCtD
Darifenacin—CYP2D6—Lovastatin—coronary artery disease	0.0252	0.0513	CbGbCtD
Darifenacin—CYP2D6—Atorvastatin—coronary artery disease	0.0229	0.0468	CbGbCtD
Darifenacin—CYP3A4—Enalapril—coronary artery disease	0.0226	0.0461	CbGbCtD
Darifenacin—CYP3A4—Rosuvastatin—coronary artery disease	0.0176	0.0359	CbGbCtD
Darifenacin—CYP3A4—Ezetimibe—coronary artery disease	0.0176	0.0359	CbGbCtD
Darifenacin—CYP3A4—Simvastatin—coronary artery disease	0.0164	0.0334	CbGbCtD
Darifenacin—CYP3A4—Lovastatin—coronary artery disease	0.016	0.0326	CbGbCtD
Darifenacin—CYP3A4—Pravastatin—coronary artery disease	0.016	0.0326	CbGbCtD
Darifenacin—CYP3A4—Atorvastatin—coronary artery disease	0.0146	0.0297	CbGbCtD
Darifenacin—CYP3A4—Losartan—coronary artery disease	0.0133	0.0272	CbGbCtD
Darifenacin—Diphenoxylate—OPRD1—coronary artery disease	0.00133	0.313	CrCbGaD
Darifenacin—Loperamide—POMC—coronary artery disease	0.000983	0.23	CrCbGaD
Darifenacin—Fentanyl—OPRD1—coronary artery disease	0.000575	0.135	CrCbGaD
Darifenacin—Loperamide—OPRD1—coronary artery disease	0.000553	0.13	CrCbGaD
Darifenacin—Methadone—OPRD1—coronary artery disease	0.000394	0.0924	CrCbGaD
Darifenacin—Clotrimazole—CYP2C19—coronary artery disease	0.000269	0.063	CrCbGaD
Darifenacin—Abdominal pain—Telmisartan—coronary artery disease	0.000167	0.00049	CcSEcCtD
Darifenacin—Dyspnoea—Losartan—coronary artery disease	0.000167	0.000489	CcSEcCtD
Darifenacin—Vomiting—Lovastatin—coronary artery disease	0.000167	0.000489	CcSEcCtD
Darifenacin—Somnolence—Losartan—coronary artery disease	0.000166	0.000488	CcSEcCtD
Darifenacin—Dizziness—Eplerenone—coronary artery disease	0.000166	0.000488	CcSEcCtD
Darifenacin—Rash—Clopidogrel—coronary artery disease	0.000166	0.000488	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000166	0.000488	CcSEcCtD
Darifenacin—Dermatitis—Clopidogrel—coronary artery disease	0.000166	0.000487	CcSEcCtD
Darifenacin—Asthenia—Valsartan—coronary artery disease	0.000166	0.000487	CcSEcCtD
Darifenacin—Hypertension—Timolol—coronary artery disease	0.000166	0.000487	CcSEcCtD
Darifenacin—Pain—Furosemide—coronary artery disease	0.000166	0.000487	CcSEcCtD
Darifenacin—Constipation—Furosemide—coronary artery disease	0.000166	0.000487	CcSEcCtD
Darifenacin—Hypersensitivity—Niacin—coronary artery disease	0.000166	0.000486	CcSEcCtD
Darifenacin—Asthenia—Olmesartan—coronary artery disease	0.000165	0.000485	CcSEcCtD
Darifenacin—Headache—Clopidogrel—coronary artery disease	0.000165	0.000485	CcSEcCtD
Darifenacin—Rash—Lovastatin—coronary artery disease	0.000165	0.000485	CcSEcCtD
Darifenacin—Dermatitis—Lovastatin—coronary artery disease	0.000165	0.000484	CcSEcCtD
Darifenacin—Dyspepsia—Losartan—coronary artery disease	0.000165	0.000483	CcSEcCtD
Darifenacin—Feeling abnormal—Perindopril—coronary artery disease	0.000164	0.000482	CcSEcCtD
Darifenacin—Headache—Lovastatin—coronary artery disease	0.000164	0.000481	CcSEcCtD
Darifenacin—Pruritus—Valsartan—coronary artery disease	0.000164	0.00048	CcSEcCtD
Darifenacin—Dry mouth—Ramipril—coronary artery disease	0.000164	0.00048	CcSEcCtD
Darifenacin—Arthralgia—Timolol—coronary artery disease	0.000164	0.00048	CcSEcCtD
Darifenacin—Vomiting—Ezetimibe—coronary artery disease	0.000163	0.000479	CcSEcCtD
Darifenacin—Hypersensitivity—Pravastatin—coronary artery disease	0.000163	0.000479	CcSEcCtD
Darifenacin—Gastrointestinal pain—Perindopril—coronary artery disease	0.000163	0.000479	CcSEcCtD
Darifenacin—Angioedema—Lisinopril—coronary artery disease	0.000163	0.000478	CcSEcCtD
Darifenacin—Pruritus—Olmesartan—coronary artery disease	0.000163	0.000478	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000163	0.000477	CcSEcCtD
Darifenacin—Abdominal pain—Captopril—coronary artery disease	0.000163	0.000477	CcSEcCtD
Darifenacin—Dizziness—Simvastatin—coronary artery disease	0.000162	0.000475	CcSEcCtD
Darifenacin—Rash—Ezetimibe—coronary artery disease	0.000162	0.000475	CcSEcCtD
Darifenacin—Dermatitis—Ezetimibe—coronary artery disease	0.000162	0.000475	CcSEcCtD
Darifenacin—Confusional state—Ramipril—coronary artery disease	0.000162	0.000475	CcSEcCtD
Darifenacin—Asthenia—Niacin—coronary artery disease	0.000161	0.000474	CcSEcCtD
Darifenacin—Headache—Ezetimibe—coronary artery disease	0.000161	0.000472	CcSEcCtD
Darifenacin—Anaphylactic shock—Ramipril—coronary artery disease	0.000161	0.000471	CcSEcCtD
Darifenacin—Oedema—Ramipril—coronary artery disease	0.000161	0.000471	CcSEcCtD
Darifenacin—Dry mouth—Timolol—coronary artery disease	0.00016	0.00047	CcSEcCtD
Darifenacin—Pain—Losartan—coronary artery disease	0.00016	0.000469	CcSEcCtD
Darifenacin—Constipation—Losartan—coronary artery disease	0.00016	0.000469	CcSEcCtD
Darifenacin—Syncope—Lisinopril—coronary artery disease	0.00016	0.000469	CcSEcCtD
Darifenacin—Vomiting—Eplerenone—coronary artery disease	0.00016	0.000469	CcSEcCtD
Darifenacin—Feeling abnormal—Furosemide—coronary artery disease	0.00016	0.000469	CcSEcCtD
Darifenacin—Nausea—Fenofibrate—coronary artery disease	0.000159	0.000467	CcSEcCtD
Darifenacin—Pruritus—Niacin—coronary artery disease	0.000159	0.000467	CcSEcCtD
Darifenacin—Asthenia—Pravastatin—coronary artery disease	0.000159	0.000466	CcSEcCtD
Darifenacin—Gastrointestinal pain—Furosemide—coronary artery disease	0.000159	0.000465	CcSEcCtD
Darifenacin—Rash—Eplerenone—coronary artery disease	0.000159	0.000465	CcSEcCtD
Darifenacin—Hypersensitivity—Trandolapril—coronary artery disease	0.000159	0.000465	CcSEcCtD
Darifenacin—Dermatitis—Eplerenone—coronary artery disease	0.000158	0.000465	CcSEcCtD
Darifenacin—Diarrhoea—Valsartan—coronary artery disease	0.000158	0.000464	CcSEcCtD
Darifenacin—Confusional state—Timolol—coronary artery disease	0.000158	0.000464	CcSEcCtD
Darifenacin—Shock—Ramipril—coronary artery disease	0.000158	0.000463	CcSEcCtD
Darifenacin—Hypersensitivity—Enalapril—coronary artery disease	0.000158	0.000463	CcSEcCtD
Darifenacin—Abdominal pain—Perindopril—coronary artery disease	0.000158	0.000463	CcSEcCtD
Darifenacin—Palpitations—Lisinopril—coronary artery disease	0.000158	0.000462	CcSEcCtD
Darifenacin—Diarrhoea—Olmesartan—coronary artery disease	0.000158	0.000462	CcSEcCtD
Darifenacin—Headache—Eplerenone—coronary artery disease	0.000158	0.000462	CcSEcCtD
Darifenacin—Methadone—CYP2C19—coronary artery disease	0.000157	0.0369	CrCbGaD
Darifenacin—Nervous system disorder—Ramipril—coronary artery disease	0.000157	0.000462	CcSEcCtD
Darifenacin—Anaphylactic shock—Timolol—coronary artery disease	0.000157	0.00046	CcSEcCtD
Darifenacin—Oedema—Timolol—coronary artery disease	0.000157	0.00046	CcSEcCtD
Darifenacin—Pruritus—Pravastatin—coronary artery disease	0.000157	0.00046	CcSEcCtD
Darifenacin—Loss of consciousness—Lisinopril—coronary artery disease	0.000157	0.00046	CcSEcCtD
Darifenacin—Nausea—Clopidogrel—coronary artery disease	0.000157	0.00046	CcSEcCtD
Darifenacin—Tachycardia—Ramipril—coronary artery disease	0.000157	0.000459	CcSEcCtD
Darifenacin—Skin disorder—Ramipril—coronary artery disease	0.000156	0.000457	CcSEcCtD
Darifenacin—Infection—Timolol—coronary artery disease	0.000156	0.000457	CcSEcCtD
Darifenacin—Vomiting—Simvastatin—coronary artery disease	0.000156	0.000457	CcSEcCtD
Darifenacin—Hypersensitivity—Telmisartan—coronary artery disease	0.000156	0.000457	CcSEcCtD
Darifenacin—Cough—Lisinopril—coronary artery disease	0.000156	0.000456	CcSEcCtD
Darifenacin—Nausea—Lovastatin—coronary artery disease	0.000156	0.000456	CcSEcCtD
Darifenacin—Hyperhidrosis—Ramipril—coronary artery disease	0.000155	0.000455	CcSEcCtD
Darifenacin—Rash—Simvastatin—coronary artery disease	0.000155	0.000453	CcSEcCtD
Darifenacin—Dermatitis—Simvastatin—coronary artery disease	0.000154	0.000453	CcSEcCtD
Darifenacin—Asthenia—Trandolapril—coronary artery disease	0.000154	0.000453	CcSEcCtD
Darifenacin—Shock—Timolol—coronary artery disease	0.000154	0.000453	CcSEcCtD
Darifenacin—Feeling abnormal—Losartan—coronary artery disease	0.000154	0.000452	CcSEcCtD
Darifenacin—Diarrhoea—Niacin—coronary artery disease	0.000154	0.000452	CcSEcCtD
Darifenacin—Nervous system disorder—Timolol—coronary artery disease	0.000154	0.000451	CcSEcCtD
Darifenacin—Asthenia—Enalapril—coronary artery disease	0.000154	0.000451	CcSEcCtD
Darifenacin—Headache—Simvastatin—coronary artery disease	0.000154	0.00045	CcSEcCtD
Darifenacin—Abdominal pain—Furosemide—coronary artery disease	0.000153	0.00045	CcSEcCtD
Darifenacin—Gastrointestinal pain—Losartan—coronary artery disease	0.000153	0.000449	CcSEcCtD
Darifenacin—Dizziness—Valsartan—coronary artery disease	0.000153	0.000449	CcSEcCtD
Darifenacin—Nausea—Ezetimibe—coronary artery disease	0.000153	0.000448	CcSEcCtD
Darifenacin—Skin disorder—Timolol—coronary artery disease	0.000152	0.000447	CcSEcCtD
Darifenacin—Dizziness—Olmesartan—coronary artery disease	0.000152	0.000447	CcSEcCtD
Darifenacin—Pruritus—Trandolapril—coronary artery disease	0.000152	0.000446	CcSEcCtD
Darifenacin—Arthralgia—Lisinopril—coronary artery disease	0.000152	0.000445	CcSEcCtD
Darifenacin—Hyperhidrosis—Timolol—coronary artery disease	0.000152	0.000445	CcSEcCtD
Darifenacin—Asthenia—Telmisartan—coronary artery disease	0.000152	0.000445	CcSEcCtD
Darifenacin—Pruritus—Enalapril—coronary artery disease	0.000152	0.000445	CcSEcCtD
Darifenacin—Diarrhoea—Pravastatin—coronary artery disease	0.000152	0.000445	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000151	0.000442	CcSEcCtD
Darifenacin—Pruritus—Telmisartan—coronary artery disease	0.00015	0.000439	CcSEcCtD
Darifenacin—Nausea—Eplerenone—coronary artery disease	0.000149	0.000438	CcSEcCtD
Darifenacin—Dizziness—Niacin—coronary artery disease	0.000149	0.000436	CcSEcCtD
Darifenacin—Dry mouth—Lisinopril—coronary artery disease	0.000149	0.000436	CcSEcCtD
Darifenacin—Abdominal pain—Losartan—coronary artery disease	0.000148	0.000434	CcSEcCtD
Darifenacin—Asthenia—Captopril—coronary artery disease	0.000148	0.000433	CcSEcCtD
Darifenacin—Diarrhoea—Trandolapril—coronary artery disease	0.000147	0.000432	CcSEcCtD
Darifenacin—Vomiting—Valsartan—coronary artery disease	0.000147	0.000432	CcSEcCtD
Darifenacin—Confusional state—Lisinopril—coronary artery disease	0.000147	0.00043	CcSEcCtD
Darifenacin—Diarrhoea—Enalapril—coronary artery disease	0.000147	0.00043	CcSEcCtD
Darifenacin—Dizziness—Pravastatin—coronary artery disease	0.000147	0.00043	CcSEcCtD
Darifenacin—Vomiting—Olmesartan—coronary artery disease	0.000146	0.00043	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000146	0.000429	CcSEcCtD
Darifenacin—Rash—Valsartan—coronary artery disease	0.000146	0.000428	CcSEcCtD
Darifenacin—Dermatitis—Valsartan—coronary artery disease	0.000146	0.000428	CcSEcCtD
Darifenacin—Nausea—Simvastatin—coronary artery disease	0.000146	0.000427	CcSEcCtD
Darifenacin—Anaphylactic shock—Lisinopril—coronary artery disease	0.000146	0.000427	CcSEcCtD
Darifenacin—Oedema—Lisinopril—coronary artery disease	0.000146	0.000427	CcSEcCtD
Darifenacin—Pruritus—Captopril—coronary artery disease	0.000145	0.000427	CcSEcCtD
Darifenacin—Rash—Olmesartan—coronary artery disease	0.000145	0.000426	CcSEcCtD
Darifenacin—Insomnia—Ramipril—coronary artery disease	0.000145	0.000426	CcSEcCtD
Darifenacin—Dermatitis—Olmesartan—coronary artery disease	0.000145	0.000426	CcSEcCtD
Darifenacin—Headache—Valsartan—coronary artery disease	0.000145	0.000425	CcSEcCtD
Darifenacin—Diarrhoea—Telmisartan—coronary artery disease	0.000145	0.000424	CcSEcCtD
Darifenacin—Infection—Lisinopril—coronary artery disease	0.000145	0.000424	CcSEcCtD
Darifenacin—Headache—Olmesartan—coronary artery disease	0.000144	0.000423	CcSEcCtD
Darifenacin—Shock—Lisinopril—coronary artery disease	0.000143	0.00042	CcSEcCtD
Darifenacin—Asthenia—Perindopril—coronary artery disease	0.000143	0.00042	CcSEcCtD
Darifenacin—Dyspnoea—Ramipril—coronary artery disease	0.000143	0.00042	CcSEcCtD
Darifenacin—Vomiting—Niacin—coronary artery disease	0.000143	0.00042	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000143	0.000419	CcSEcCtD
Darifenacin—Hypersensitivity—Furosemide—coronary artery disease	0.000143	0.000419	CcSEcCtD
Darifenacin—Somnolence—Ramipril—coronary artery disease	0.000143	0.000419	CcSEcCtD
Darifenacin—Dizziness—Trandolapril—coronary artery disease	0.000142	0.000417	CcSEcCtD
Darifenacin—Tachycardia—Lisinopril—coronary artery disease	0.000142	0.000417	CcSEcCtD
Darifenacin—Insomnia—Timolol—coronary artery disease	0.000142	0.000416	CcSEcCtD
Darifenacin—Rash—Niacin—coronary artery disease	0.000142	0.000416	CcSEcCtD
Darifenacin—Dermatitis—Niacin—coronary artery disease	0.000142	0.000416	CcSEcCtD
Darifenacin—Dizziness—Enalapril—coronary artery disease	0.000142	0.000416	CcSEcCtD
Darifenacin—Skin disorder—Lisinopril—coronary artery disease	0.000141	0.000415	CcSEcCtD
Darifenacin—Dyspepsia—Ramipril—coronary artery disease	0.000141	0.000414	CcSEcCtD
Darifenacin—Pruritus—Perindopril—coronary artery disease	0.000141	0.000414	CcSEcCtD
Darifenacin—Headache—Niacin—coronary artery disease	0.000141	0.000413	CcSEcCtD
Darifenacin—Vomiting—Pravastatin—coronary artery disease	0.000141	0.000413	CcSEcCtD
Darifenacin—Hyperhidrosis—Lisinopril—coronary artery disease	0.000141	0.000413	CcSEcCtD
Darifenacin—Diarrhoea—Captopril—coronary artery disease	0.000141	0.000412	CcSEcCtD
Darifenacin—Dyspnoea—Timolol—coronary artery disease	0.00014	0.00041	CcSEcCtD
Darifenacin—Dizziness—Telmisartan—coronary artery disease	0.00014	0.00041	CcSEcCtD
Darifenacin—Rash—Pravastatin—coronary artery disease	0.00014	0.00041	CcSEcCtD
Darifenacin—Dermatitis—Pravastatin—coronary artery disease	0.00014	0.000409	CcSEcCtD
Darifenacin—Somnolence—Timolol—coronary artery disease	0.00014	0.000409	CcSEcCtD
Darifenacin—Asthenia—Furosemide—coronary artery disease	0.000139	0.000408	CcSEcCtD
Darifenacin—Headache—Pravastatin—coronary artery disease	0.000139	0.000407	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000139	0.000406	CcSEcCtD
Darifenacin—Dyspepsia—Timolol—coronary artery disease	0.000138	0.000405	CcSEcCtD
Darifenacin—Hypersensitivity—Losartan—coronary artery disease	0.000138	0.000404	CcSEcCtD
Darifenacin—Nausea—Valsartan—coronary artery disease	0.000138	0.000403	CcSEcCtD
Darifenacin—Pruritus—Furosemide—coronary artery disease	0.000137	0.000403	CcSEcCtD
Darifenacin—Constipation—Ramipril—coronary artery disease	0.000137	0.000403	CcSEcCtD
Darifenacin—Nausea—Olmesartan—coronary artery disease	0.000137	0.000401	CcSEcCtD
Darifenacin—Vomiting—Trandolapril—coronary artery disease	0.000137	0.000401	CcSEcCtD
Darifenacin—Diarrhoea—Perindopril—coronary artery disease	0.000137	0.0004	CcSEcCtD
Darifenacin—Vomiting—Enalapril—coronary artery disease	0.000136	0.0004	CcSEcCtD
Darifenacin—Dizziness—Captopril—coronary artery disease	0.000136	0.000399	CcSEcCtD
Darifenacin—Rash—Trandolapril—coronary artery disease	0.000136	0.000398	CcSEcCtD
Darifenacin—Dermatitis—Trandolapril—coronary artery disease	0.000136	0.000398	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Timolol—coronary artery disease	0.000135	0.000397	CcSEcCtD
Darifenacin—Rash—Enalapril—coronary artery disease	0.000135	0.000396	CcSEcCtD
Darifenacin—Dermatitis—Enalapril—coronary artery disease	0.000135	0.000396	CcSEcCtD
Darifenacin—Headache—Trandolapril—coronary artery disease	0.000135	0.000395	CcSEcCtD
Darifenacin—Vomiting—Telmisartan—coronary artery disease	0.000134	0.000394	CcSEcCtD
Darifenacin—Asthenia—Losartan—coronary artery disease	0.000134	0.000394	CcSEcCtD
Darifenacin—Headache—Enalapril—coronary artery disease	0.000134	0.000394	CcSEcCtD
Darifenacin—Pain—Timolol—coronary artery disease	0.000134	0.000394	CcSEcCtD
Darifenacin—Nausea—Niacin—coronary artery disease	0.000134	0.000392	CcSEcCtD
Darifenacin—Rash—Telmisartan—coronary artery disease	0.000133	0.000391	CcSEcCtD
Darifenacin—Dermatitis—Telmisartan—coronary artery disease	0.000133	0.000391	CcSEcCtD
Darifenacin—Diarrhoea—Furosemide—coronary artery disease	0.000133	0.000389	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000133	0.000389	CcSEcCtD
Darifenacin—Pruritus—Losartan—coronary artery disease	0.000132	0.000388	CcSEcCtD
Darifenacin—Headache—Telmisartan—coronary artery disease	0.000132	0.000388	CcSEcCtD
Darifenacin—Feeling abnormal—Ramipril—coronary artery disease	0.000132	0.000388	CcSEcCtD
Darifenacin—Dizziness—Perindopril—coronary artery disease	0.000132	0.000387	CcSEcCtD
Darifenacin—Insomnia—Lisinopril—coronary artery disease	0.000132	0.000386	CcSEcCtD
Darifenacin—Nausea—Pravastatin—coronary artery disease	0.000132	0.000386	CcSEcCtD
Darifenacin—Gastrointestinal pain—Ramipril—coronary artery disease	0.000131	0.000385	CcSEcCtD
Darifenacin—Vomiting—Captopril—coronary artery disease	0.000131	0.000383	CcSEcCtD
Darifenacin—Dyspnoea—Lisinopril—coronary artery disease	0.00013	0.000381	CcSEcCtD
Darifenacin—Rash—Captopril—coronary artery disease	0.00013	0.00038	CcSEcCtD
Darifenacin—Dermatitis—Captopril—coronary artery disease	0.00013	0.00038	CcSEcCtD
Darifenacin—Somnolence—Lisinopril—coronary artery disease	0.000129	0.00038	CcSEcCtD
Darifenacin—Feeling abnormal—Timolol—coronary artery disease	0.000129	0.000379	CcSEcCtD
Darifenacin—Headache—Captopril—coronary artery disease	0.000129	0.000378	CcSEcCtD
Darifenacin—Gastrointestinal pain—Timolol—coronary artery disease	0.000128	0.000376	CcSEcCtD
Darifenacin—Dizziness—Furosemide—coronary artery disease	0.000128	0.000376	CcSEcCtD
Darifenacin—Dyspepsia—Lisinopril—coronary artery disease	0.000128	0.000376	CcSEcCtD
Darifenacin—Diarrhoea—Losartan—coronary artery disease	0.000128	0.000376	CcSEcCtD
Darifenacin—Nausea—Trandolapril—coronary artery disease	0.000128	0.000375	CcSEcCtD
Darifenacin—Nausea—Enalapril—coronary artery disease	0.000127	0.000373	CcSEcCtD
Darifenacin—Vomiting—Perindopril—coronary artery disease	0.000127	0.000372	CcSEcCtD
Darifenacin—Abdominal pain—Ramipril—coronary artery disease	0.000127	0.000372	CcSEcCtD
Darifenacin—Rash—Perindopril—coronary artery disease	0.000126	0.000369	CcSEcCtD
Darifenacin—Dermatitis—Perindopril—coronary artery disease	0.000126	0.000369	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000126	0.000369	CcSEcCtD
Darifenacin—Nausea—Telmisartan—coronary artery disease	0.000126	0.000368	CcSEcCtD
Darifenacin—Headache—Perindopril—coronary artery disease	0.000125	0.000367	CcSEcCtD
Darifenacin—Constipation—Lisinopril—coronary artery disease	0.000125	0.000365	CcSEcCtD
Darifenacin—Pain—Lisinopril—coronary artery disease	0.000125	0.000365	CcSEcCtD
Darifenacin—Abdominal pain—Timolol—coronary artery disease	0.000124	0.000364	CcSEcCtD
Darifenacin—Dizziness—Losartan—coronary artery disease	0.000124	0.000363	CcSEcCtD
Darifenacin—Vomiting—Furosemide—coronary artery disease	0.000123	0.000362	CcSEcCtD
Darifenacin—Rash—Furosemide—coronary artery disease	0.000122	0.000359	CcSEcCtD
Darifenacin—Dermatitis—Furosemide—coronary artery disease	0.000122	0.000358	CcSEcCtD
Darifenacin—Nausea—Captopril—coronary artery disease	0.000122	0.000358	CcSEcCtD
Darifenacin—Headache—Furosemide—coronary artery disease	0.000122	0.000356	CcSEcCtD
Darifenacin—Feeling abnormal—Lisinopril—coronary artery disease	0.00012	0.000352	CcSEcCtD
Darifenacin—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000119	0.000349	CcSEcCtD
Darifenacin—Vomiting—Losartan—coronary artery disease	0.000119	0.000349	CcSEcCtD
Darifenacin—Nausea—Perindopril—coronary artery disease	0.000119	0.000348	CcSEcCtD
Darifenacin—Hypersensitivity—Ramipril—coronary artery disease	0.000118	0.000347	CcSEcCtD
Darifenacin—Rash—Losartan—coronary artery disease	0.000118	0.000346	CcSEcCtD
Darifenacin—Dermatitis—Losartan—coronary artery disease	0.000118	0.000346	CcSEcCtD
Darifenacin—Headache—Losartan—coronary artery disease	0.000117	0.000344	CcSEcCtD
Darifenacin—Hypersensitivity—Timolol—coronary artery disease	0.000116	0.000339	CcSEcCtD
Darifenacin—Nausea—Furosemide—coronary artery disease	0.000115	0.000338	CcSEcCtD
Darifenacin—Asthenia—Ramipril—coronary artery disease	0.000115	0.000338	CcSEcCtD
Darifenacin—Abdominal pain—Lisinopril—coronary artery disease	0.000115	0.000337	CcSEcCtD
Darifenacin—Pruritus—Ramipril—coronary artery disease	0.000114	0.000333	CcSEcCtD
Darifenacin—Asthenia—Timolol—coronary artery disease	0.000113	0.00033	CcSEcCtD
Darifenacin—Nausea—Losartan—coronary artery disease	0.000111	0.000326	CcSEcCtD
Darifenacin—Pruritus—Timolol—coronary artery disease	0.000111	0.000326	CcSEcCtD
Darifenacin—Diarrhoea—Ramipril—coronary artery disease	0.00011	0.000322	CcSEcCtD
Darifenacin—Diarrhoea—Timolol—coronary artery disease	0.000107	0.000315	CcSEcCtD
Darifenacin—Hypersensitivity—Lisinopril—coronary artery disease	0.000107	0.000315	CcSEcCtD
Darifenacin—Dizziness—Ramipril—coronary artery disease	0.000106	0.000311	CcSEcCtD
Darifenacin—Asthenia—Lisinopril—coronary artery disease	0.000104	0.000306	CcSEcCtD
Darifenacin—Dizziness—Timolol—coronary artery disease	0.000104	0.000304	CcSEcCtD
Darifenacin—Pruritus—Lisinopril—coronary artery disease	0.000103	0.000302	CcSEcCtD
Darifenacin—Vomiting—Ramipril—coronary artery disease	0.000102	0.000299	CcSEcCtD
Darifenacin—Rash—Ramipril—coronary artery disease	0.000101	0.000297	CcSEcCtD
Darifenacin—Dermatitis—Ramipril—coronary artery disease	0.000101	0.000297	CcSEcCtD
Darifenacin—Headache—Ramipril—coronary artery disease	0.000101	0.000295	CcSEcCtD
Darifenacin—Vomiting—Timolol—coronary artery disease	9.98e-05	0.000293	CcSEcCtD
Darifenacin—Diarrhoea—Lisinopril—coronary artery disease	9.96e-05	0.000292	CcSEcCtD
Darifenacin—Rash—Timolol—coronary artery disease	9.9e-05	0.00029	CcSEcCtD
Darifenacin—Dermatitis—Timolol—coronary artery disease	9.89e-05	0.00029	CcSEcCtD
Darifenacin—Headache—Timolol—coronary artery disease	9.83e-05	0.000288	CcSEcCtD
Darifenacin—Dizziness—Lisinopril—coronary artery disease	9.63e-05	0.000282	CcSEcCtD
Darifenacin—Nausea—Ramipril—coronary artery disease	9.54e-05	0.00028	CcSEcCtD
Darifenacin—Nausea—Timolol—coronary artery disease	9.32e-05	0.000273	CcSEcCtD
Darifenacin—Vomiting—Lisinopril—coronary artery disease	9.26e-05	0.000271	CcSEcCtD
Darifenacin—Rash—Lisinopril—coronary artery disease	9.18e-05	0.000269	CcSEcCtD
Darifenacin—Dermatitis—Lisinopril—coronary artery disease	9.17e-05	0.000269	CcSEcCtD
Darifenacin—Headache—Lisinopril—coronary artery disease	9.12e-05	0.000267	CcSEcCtD
Darifenacin—Nausea—Lisinopril—coronary artery disease	8.65e-05	0.000254	CcSEcCtD
Darifenacin—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	8.23e-06	5.01e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—FGF2—coronary artery disease	8.15e-06	4.96e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	8.14e-06	4.95e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	8.11e-06	4.94e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	8.1e-06	4.93e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PLCB1—coronary artery disease	8.09e-06	4.92e-05	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—PIK3CA—coronary artery disease	8.08e-06	4.92e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	8.07e-06	4.91e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SERPINE1—coronary artery disease	8.06e-06	4.91e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NOS3—coronary artery disease	8.04e-06	4.89e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PLCB3—coronary artery disease	8.04e-06	4.89e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	8.04e-06	4.89e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	8e-06	4.87e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOA5—coronary artery disease	7.96e-06	4.84e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	7.95e-06	4.84e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	7.93e-06	4.83e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	7.85e-06	4.78e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ABCA1—coronary artery disease	7.84e-06	4.77e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—JAK2—coronary artery disease	7.81e-06	4.76e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—FGF2—coronary artery disease	7.81e-06	4.75e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—P4HB—coronary artery disease	7.8e-06	4.75e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	7.78e-06	4.74e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—C3—coronary artery disease	7.77e-06	4.73e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	7.76e-06	4.72e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—C3—coronary artery disease	7.75e-06	4.72e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NOS3—coronary artery disease	7.7e-06	4.69e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	7.68e-06	4.68e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—C3—coronary artery disease	7.67e-06	4.67e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	7.66e-06	4.66e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PIK3CA—coronary artery disease	7.66e-06	4.66e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GGT1—coronary artery disease	7.59e-06	4.62e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GOT1—coronary artery disease	7.59e-06	4.62e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PPARG—coronary artery disease	7.51e-06	4.57e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—JAK2—coronary artery disease	7.48e-06	4.55e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	7.41e-06	4.51e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—POMC—coronary artery disease	7.41e-06	4.51e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	7.39e-06	4.5e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AGT—coronary artery disease	7.39e-06	4.49e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AGT—coronary artery disease	7.36e-06	4.48e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PIK3CA—coronary artery disease	7.33e-06	4.46e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	7.32e-06	4.45e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AGT—coronary artery disease	7.29e-06	4.44e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—LEP—coronary artery disease	7.24e-06	4.4e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOE—coronary artery disease	7.24e-06	4.4e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—VCAN—coronary artery disease	7.22e-06	4.39e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LEP—coronary artery disease	7.21e-06	4.39e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOE—coronary artery disease	7.21e-06	4.39e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALDOA—coronary artery disease	7.16e-06	4.36e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APOA1—coronary artery disease	7.15e-06	4.35e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOE—coronary artery disease	7.14e-06	4.35e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LEP—coronary artery disease	7.14e-06	4.35e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CXCL8—coronary artery disease	7.13e-06	4.34e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APOA1—coronary artery disease	7.13e-06	4.34e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KDR—coronary artery disease	7.09e-06	4.31e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KDR—coronary artery disease	7.07e-06	4.3e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APOA1—coronary artery disease	7.06e-06	4.3e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	7.04e-06	4.29e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	7.02e-06	4.27e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KDR—coronary artery disease	7e-06	4.26e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—DCN—coronary artery disease	6.95e-06	4.23e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	6.95e-06	4.23e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ESR1—coronary artery disease	6.91e-06	4.2e-05	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—AKT1—coronary artery disease	6.89e-06	4.19e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ESR1—coronary artery disease	6.89e-06	4.19e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CXCL8—coronary artery disease	6.83e-06	4.16e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CASP3—coronary artery disease	6.83e-06	4.15e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FN1—coronary artery disease	6.82e-06	4.15e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—F2—coronary artery disease	6.82e-06	4.15e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTP1—coronary artery disease	6.82e-06	4.15e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ESR1—coronary artery disease	6.82e-06	4.15e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FN1—coronary artery disease	6.8e-06	4.14e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—F2—coronary artery disease	6.8e-06	4.14e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	6.8e-06	4.14e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—coronary artery disease	6.78e-06	4.13e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	6.78e-06	4.12e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALDH2—coronary artery disease	6.77e-06	4.12e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	6.76e-06	4.11e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ALB—coronary artery disease	6.76e-06	4.11e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	6.74e-06	4.1e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FN1—coronary artery disease	6.74e-06	4.1e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—F2—coronary artery disease	6.74e-06	4.1e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—HMOX1—coronary artery disease	6.73e-06	4.09e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	6.72e-06	4.09e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	6.71e-06	4.08e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	6.66e-06	4.05e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCND1—coronary artery disease	6.64e-06	4.04e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CAT—coronary artery disease	6.64e-06	4.04e-05	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—AKT1—coronary artery disease	6.6e-06	4.02e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP2C19—coronary artery disease	6.59e-06	4.01e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	6.59e-06	4.01e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—LIPC—coronary artery disease	6.59e-06	4.01e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HBA1—coronary artery disease	6.59e-06	4.01e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOC3—coronary artery disease	6.55e-06	3.99e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CASP3—coronary artery disease	6.54e-06	3.98e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KIT—coronary artery disease	6.53e-06	3.97e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—LDLR—coronary artery disease	6.51e-06	3.96e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KIT—coronary artery disease	6.51e-06	3.96e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—coronary artery disease	6.49e-06	3.95e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—NOS3—coronary artery disease	6.46e-06	3.93e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MMP9—coronary artery disease	6.45e-06	3.93e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KIT—coronary artery disease	6.45e-06	3.92e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOB—coronary artery disease	6.44e-06	3.92e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTT1—coronary artery disease	6.43e-06	3.92e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SLC9A1—coronary artery disease	6.43e-06	3.92e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCND1—coronary artery disease	6.36e-06	3.87e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GCLC—coronary artery disease	6.36e-06	3.87e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CETP—coronary artery disease	6.36e-06	3.87e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—SDC1—coronary artery disease	6.29e-06	3.83e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GSTM1—coronary artery disease	6.27e-06	3.82e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	6.27e-06	3.81e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—AKT1—coronary artery disease	6.26e-06	3.81e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	6.25e-06	3.8e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—POMC—coronary artery disease	6.22e-06	3.78e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CREB1—coronary artery disease	6.22e-06	3.78e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—POMC—coronary artery disease	6.2e-06	3.77e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CREB1—coronary artery disease	6.2e-06	3.77e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	6.19e-06	3.76e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MMP9—coronary artery disease	6.18e-06	3.76e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—LPL—coronary artery disease	6.15e-06	3.74e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—POMC—coronary artery disease	6.14e-06	3.73e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CREB1—coronary artery disease	6.14e-06	3.73e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCL2—coronary artery disease	6.08e-06	3.7e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6R—coronary artery disease	6.06e-06	3.69e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCL2—coronary artery disease	6.06e-06	3.69e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6R—coronary artery disease	6.04e-06	3.68e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCL2—coronary artery disease	6e-06	3.65e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GPX1—coronary artery disease	6e-06	3.65e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—AKT1—coronary artery disease	5.99e-06	3.65e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6R—coronary artery disease	5.99e-06	3.64e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1—coronary artery disease	5.98e-06	3.64e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1—coronary artery disease	5.96e-06	3.63e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	5.95e-06	3.62e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PSMA6—coronary artery disease	5.94e-06	3.62e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PSMB5—coronary artery disease	5.94e-06	3.62e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	5.93e-06	3.61e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PTGS2—coronary artery disease	5.91e-06	3.6e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1—coronary artery disease	5.9e-06	3.59e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	5.87e-06	3.58e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CD36—coronary artery disease	5.85e-06	3.56e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CTGF—coronary artery disease	5.8e-06	3.53e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VEGFA—coronary artery disease	5.79e-06	3.53e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPP2CA—coronary artery disease	5.77e-06	3.51e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HMGCR—coronary artery disease	5.75e-06	3.5e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GOT2—coronary artery disease	5.75e-06	3.5e-05	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	5.69e-06	3.46e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	5.68e-06	3.46e-05	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	5.67e-06	3.45e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	5.66e-06	3.44e-05	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	5.61e-06	3.42e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	5.61e-06	3.41e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VEGFA—coronary artery disease	5.55e-06	3.38e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MTHFR—coronary artery disease	5.54e-06	3.37e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FGF2—coronary artery disease	5.5e-06	3.35e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FGF2—coronary artery disease	5.48e-06	3.33e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FGF2—coronary artery disease	5.43e-06	3.3e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOS3—coronary artery disease	5.42e-06	3.3e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOS3—coronary artery disease	5.4e-06	3.29e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOS3—coronary artery disease	5.35e-06	3.26e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TGFB1—coronary artery disease	5.32e-06	3.24e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.29e-06	3.22e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—JAK2—coronary artery disease	5.27e-06	3.21e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AGT—coronary artery disease	5.26e-06	3.2e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—JAK2—coronary artery disease	5.25e-06	3.2e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MAPK1—coronary artery disease	5.21e-06	3.17e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—JAK2—coronary artery disease	5.2e-06	3.17e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	5.16e-06	3.14e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOE—coronary artery disease	5.16e-06	3.14e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	5.15e-06	3.13e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.13e-06	3.12e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—APOA1—coronary artery disease	5.1e-06	3.1e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	5.1e-06	3.1e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	5.09e-06	3.1e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	4.99e-06	3.04e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GOT1—coronary artery disease	4.97e-06	3.02e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GGT1—coronary artery disease	4.97e-06	3.02e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	4.81e-06	2.93e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	4.79e-06	2.92e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	4.75e-06	2.89e-05	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	4.65e-06	2.83e-05	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	4.63e-06	2.82e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CASP3—coronary artery disease	4.6e-06	2.8e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CASP3—coronary artery disease	4.59e-06	2.79e-05	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	4.59e-06	2.79e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—coronary artery disease	4.57e-06	2.78e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—coronary artery disease	4.56e-06	2.77e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CASP3—coronary artery disease	4.54e-06	2.77e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	4.52e-06	2.75e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—coronary artery disease	4.51e-06	2.75e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PPARG—coronary artery disease	4.49e-06	2.73e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCND1—coronary artery disease	4.48e-06	2.73e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCND1—coronary artery disease	4.47e-06	2.72e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTP1—coronary artery disease	4.46e-06	2.71e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—POMC—coronary artery disease	4.43e-06	2.7e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCND1—coronary artery disease	4.42e-06	2.69e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.42e-06	2.69e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.4e-06	2.68e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MMP9—coronary artery disease	4.35e-06	2.65e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CAT—coronary artery disease	4.34e-06	2.64e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MMP9—coronary artery disease	4.34e-06	2.64e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	4.33e-06	2.64e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MMP9—coronary artery disease	4.29e-06	2.61e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	4.22e-06	2.57e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOB—coronary artery disease	4.21e-06	2.56e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	4.21e-06	2.56e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	4.16e-06	2.53e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.1e-06	2.49e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ALB—coronary artery disease	4.04e-06	2.46e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—LPL—coronary artery disease	4.02e-06	2.45e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—coronary artery disease	4.01e-06	2.44e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPX1—coronary artery disease	3.93e-06	2.39e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	3.91e-06	2.38e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	3.89e-06	2.37e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—NOS3—coronary artery disease	3.86e-06	2.35e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	3.86e-06	2.35e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—coronary artery disease	3.84e-06	2.33e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CD36—coronary artery disease	3.82e-06	2.33e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.77e-06	2.3e-05	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—AKT1—coronary artery disease	3.7e-06	2.25e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CA—coronary artery disease	3.64e-06	2.21e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.62e-06	2.2e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	3.58e-06	2.18e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	3.57e-06	2.17e-05	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—AKT1—coronary artery disease	3.54e-06	2.15e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	3.54e-06	2.15e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.53e-06	2.15e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	3.52e-06	2.14e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	3.5e-06	2.13e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	3.47e-06	2.11e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AGT—coronary artery disease	3.44e-06	2.09e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOE—coronary artery disease	3.37e-06	2.05e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—APOA1—coronary artery disease	3.33e-06	2.03e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	3.05e-06	1.86e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	3.04e-06	1.85e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	3.01e-06	1.83e-05	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—AKT1—coronary artery disease	2.97e-06	1.81e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PPARG—coronary artery disease	2.94e-06	1.79e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—POMC—coronary artery disease	2.9e-06	1.76e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—coronary artery disease	2.7e-06	1.64e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—coronary artery disease	2.69e-06	1.64e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—coronary artery disease	2.67e-06	1.62e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ALB—coronary artery disease	2.64e-06	1.61e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—NOS3—coronary artery disease	2.53e-06	1.54e-05	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—AKT1—coronary artery disease	2.49e-06	1.52e-05	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—AKT1—coronary artery disease	2.48e-06	1.51e-05	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—AKT1—coronary artery disease	2.46e-06	1.5e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.31e-06	1.41e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.17e-06	1.32e-05	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—AKT1—coronary artery disease	1.78e-06	1.08e-05	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.42e-06	8.65e-06	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—AKT1—coronary artery disease	1.16e-06	7.07e-06	CbGpPWpGaD
